Director Kim Buys 25,000 TRDA Shares

By Steve Strazza

May 16, 2024
steve strazza headshot

From the Desk of Steve Strazza and Alfonso Depablos

The only insider buy on today’s list comes via a Form 4 filing by Entrada Therapeutics Inc $TRDA director Peter S. Kim.

Kim reported the acquisition of 25,000 shares, equivalent to $364,672, in the small-cap biotech company.

Here’s The Hot Corner, with data through May 16, 2024:

240517_hot_corner_table

Have a great weekend. We’ll be back on Monday with more insider activity.

And please reach out with any questions. We love hearing from you!

Filed Under:
steve strazza headshot

Steve Strazza

Chief Market Strategist, All Star Charts

Steve Strazza brings a unique perspective to the world of Technical Analysis due to his diverse background. Steve found an affinity for financial markets during his first job out of college as a big-4 CPA auditing some of Wall Street’s largest broker-dealers, such as Interactive Brokers and Morgan Stanley. Steve then worked in the Asset Management industry in a variety of roles including Controller for a private equity start-up, Fund Accountant at two large hedge funds, and most notably as a personal Accountant for Steve Cohen at SAC Capital and Point72.

sstrazza